Format

Send to

Choose Destination
See comment in PubMed Commons below
PLoS Comput Biol. 2012;8(9):e1002706. doi: 10.1371/journal.pcbi.1002706. Epub 2012 Sep 27.

Why open drug discovery needs four simple rules for licensing data and models.

Author information

1
Royal Society of Chemistry, Wake Forest, North Carolina, USA. tony27587@gmail.com

Abstract

When we look at the rapid growth of scientific databases on the Internet in the past decade, we tend to take the accessibility and provenance of the data for granted. As we see a future of increased database integration, the licensing of the data may be a hurdle that hampers progress and usability. We have formulated four rules for licensing data for open drug discovery, which we propose as a starting point for consideration by databases and for their ultimate adoption. This work could also be extended to the computational models derived from such data. We suggest that scientists in the future will need to consider data licensing before they embark upon re-using such content in databases they construct themselves.

PMID:
23028298
PMCID:
PMC3459841
DOI:
10.1371/journal.pcbi.1002706
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Public Library of Science Icon for PubMed Central
    Loading ...
    Support Center